Fortress Biotech Inc (FBIO)
1.79
+0.04
(+2.29%)
USD |
NASDAQ |
May 06, 16:00
1.76
-0.03
(-1.68%)
Pre-Market: 09:28
Fortress Biotech Cash from Financing (TTM): 32.74M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 32.74M |
September 30, 2023 | 7.739M |
June 30, 2023 | 14.17M |
March 31, 2023 | 47.54M |
December 31, 2022 | 75.32M |
September 30, 2022 | 95.64M |
June 30, 2022 | 98.86M |
March 31, 2022 | 120.27M |
December 31, 2021 | 148.99M |
September 30, 2021 | 147.07M |
June 30, 2021 | 186.93M |
March 31, 2021 | 228.35M |
December 31, 2020 | 172.41M |
September 30, 2020 | 162.55M |
June 30, 2020 | 121.27M |
March 31, 2020 | 117.35M |
December 31, 2019 | 146.71M |
September 30, 2019 | 117.87M |
June 30, 2019 | 122.27M |
March 31, 2019 | 63.11M |
December 31, 2018 | 50.65M |
September 30, 2018 | 73.00M |
June 30, 2018 | 80.18M |
March 31, 2018 | 131.88M |
December 31, 2017 | 150.38M |
Date | Value |
---|---|
September 30, 2017 | 155.68M |
June 30, 2017 | 156.40M |
March 31, 2017 | 103.49M |
December 31, 2016 | 42.90M |
September 30, 2016 | 57.41M |
June 30, 2016 | 50.62M |
March 31, 2016 | 49.13M |
December 31, 2015 | 60.92M |
September 30, 2015 | 24.83M |
June 30, 2015 | 12.32M |
March 31, 2015 | 12.42M |
December 31, 2014 | -10.16M |
September 30, 2014 | -14.14M |
June 30, 2014 | 32.82M |
March 31, 2014 | 64.59M |
December 31, 2013 | 89.16M |
September 30, 2013 | 88.87M |
June 30, 2013 | 57.28M |
March 31, 2013 | 51.86M |
December 31, 2012 | 40.51M |
September 30, 2012 | 40.52M |
June 30, 2012 | 26.58M |
March 31, 2012 | 23.09M |
December 31, 2011 | 23.09M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
7.739M
Minimum
Sep 2023
228.35M
Maximum
Mar 2021
113.90M
Average
120.27M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Journey Medical Corp | -4.804M |
Avenue Therapeutics Inc | 7.526M |
Mustang Bio Inc | -26.08M |
Checkpoint Therapeutics Inc | 40.45M |
Viking Therapeutics Inc | 873.23M |